Vitality Equiscope

06/01/2026

05/30/2026

Really happy with the recheck on Adios today. Big thank you to Dr Lee for getting us rodeo road ready.

His radiographs looks fantastic and he was as sound as a new dollar bill! We are soooo close to his comeback and I know we are *all* ready!

This surgery went as good as possible and I’ve been back on him about 2 months now. Tiny bit of change by the screw head, but we are extremely happy with progress and thankful to Erika for being extremely dedicated to his care, equiscoping him 3 days a week.

Christi at Highpoint… well… she’s his auntie now. 🫶🏻🥰

Huge thank you to Dr Lee, Dr Marsh, Dr Sharp and Dr Honnas for all their knowledge during this time. Just super thankful to my team. 🫶🏻

05/29/2026

🙌🏻🌟🌟

05/29/2026

05/26/2026

Polyneuritis VS EPMSD

How EPMSD May Support Horses Experiencing Polyneuritis-Like Neurological Stress

A Systems-Based Educational Overview

Polyneuritis equi is a neurological condition involving inflammation of peripheral nerves—most commonly the cauda equina and sacrocaudal nerve roots. Clinical signs may include weakness, muscle atrophy, gait abnormalities, reduced tail tone, altered sensation, poor coordination, and chronic inflammation. Current veterinary literature suggests immune-mediated inflammation may play a role in some cases.
Source: Merck Veterinary Manual — Diseases of the Peripheral Nerves in Horses

EPMSD was designed around a systems-based philosophy focused on supporting multiple body systems commonly stressed during chronic neurological dysfunction. Rather than targeting only one pathway, the formula is intended to support circulation, antioxidant balance, connective tissue integrity, digestive function, bile-associated detoxification pathways, and overall systemic resilience.

⸻

1. Neuro-Immune Axis Support

Neurological inflammation is closely connected to immune signaling. Chronic inflammatory cytokines and oxidative stress may contribute to ongoing irritation surrounding nerves and supporting tissues.

MSM (methylsulfonylmethane) provides a sulfur source involved in glutathione production and antioxidant activity. Equine studies have shown MSM may help reduce exercise-associated oxidative stress and support inflammatory balance in muscle tissue.

Source:
Marañón et al., “The Effect of Methyl Sulfonyl Methane Supplementation on Biomarkers of Oxidative Stress in Sport Horses”

Cinnamon contains polyphenols and cinnamaldehyde compounds that have been studied for antioxidant and anti-inflammatory activity. These compounds may help support vascular function and healthy inflammatory signaling.

Source:
Cinnamon Polyphenols and Inflammation Review

Together, these ingredients are theorized to support the body’s ability to manage oxidative stress associated with chronic inflammation.

⸻

2. Gut–Brain Axis Support

The nervous system and digestive system are heavily interconnected. Horses experiencing chronic neurological stress often also experience digestive instability, poor nutrient absorption, altered appetite, or weight loss.

Wormwood (Artemisia absinthium) has historically been used as a bitter digestive herb. Bitter compounds may help stimulate digestive secretions and bile-associated digestive processes. Horses naturally secrete bile continuously because they do not possess a gallbladder.

Source:
Equine Digestive Physiology Review

Supporting digestion and nutrient absorption may help improve the body’s access to amino acids, minerals, and energy substrates needed for tissue maintenance and recovery.

⸻

3. Fascia–Nerve Axis Support

Fascia surrounds nerves, blood vessels, muscles, and lymphatic structures. Chronic inflammation may reduce fascial glide, hydration, and tissue elasticity.

Shavegrass (horsetail) contains silica-associated compounds traditionally linked to connective tissue support. Silica plays a role in collagen-associated structural integrity and connective tissue maintenance.

Source:
Silica and Connective Tissue Review

MSM and silica-containing plants are often discussed together in connective tissue support because sulfur and silica both contribute to structural tissue integrity.

⸻

4. Blood–Nerve Axis Support

Nervous tissue depends heavily on oxygen delivery, nutrient transport, and healthy microcirculation. Reduced circulation may impair tissue resilience and recovery capacity.

Cinnamon has been studied for vascular-supportive properties and antioxidant effects that may help support healthy blood flow dynamics.

Supporting circulation may assist nutrient delivery to stressed neuromuscular tissues.

⸻

5. Liver–Bile–Detox Axis Support

Inflammation, oxidative stress, cellular waste products, and microbial byproducts place demand on detoxification pathways.

Traditional bitter herbs like wormwood have historically been used to support digestive and biliary function. Sulfur-containing compounds like MSM are also associated with phase II detoxification support due to sulfur’s role in glutathione-related pathways.

These systems may become especially important during periods of increased inflammatory stress.

⸻

Why the 90-Day Structure Matters

Nervous tissue, connective tissue, and red blood cell turnover occur gradually over time. Tissue remodeling, inflammatory regulation, and systemic adaptation are not immediate processes.

The 90-day structure was developed around:
• Progressive systemic support
• Tissue turnover timelines
• Connective tissue maintenance
• Nutritional replenishment
• Gradual neurological stabilization support

⸻

Summary

EPMSD is positioned as a multi-system botanical support formula intended to help maintain:
• Healthy inflammatory balance
• Connective tissue integrity
• Digestive and bile-associated function
• Circulatory support
• Antioxidant activity
• Detoxification pathways
• Overall neurological resilience

This systems-based approach reflects the understanding that neurological dysfunction often affects far more than nerves alone.

⸻

Sources:
• Merck Veterinary Manual – Peripheral Nerve Diseases in Horses

• Marañón et al. – MSM and Oxidative Stress in Horses

• Cinnamon Polyphenols and Inflammation Review

• Equine Digestive Physiology Review

• Silica and Connective Tissue Review

⸻

Old West Holistic Company
[email protected]
866-437-6397

Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. EPMSD is not a substitute for veterinary care. Always consult with your veterinarian regarding your horse’s individual health needs.

05/25/2026

The Sugar Spike No One Talks About: What Guanabenz Can Do to Blood Sugar in Horses

Guanabenz is often praised in the racing and performance world for its calming effect—used to “take the edge off,” manage pulmonary pressure, or support horses with exercise-induced bleeding. But there’s a metabolic side of guanabenz that rarely gets discussed—and it matters deeply for horses with any hint of blood sugar imbalance.

Let’s talk about the silent sugar surge.

⸻

Guanabenz and Blood Sugar: What’s the Connection?

Guanabenz is a central alpha-2 adrenergic agonist, meaning it suppresses sympathetic nervous system output. That’s part of why it’s so effective for sedation and calming. But what many don’t realize is that this mechanism also inhibits insulin secretion and temporarily increases blood glucose levels .

In a controlled study at the University of Kentucky, horses given guanabenz experienced:
• Significant hyperglycemia (elevated blood sugar)
• Glucosuria (glucose spilling into the urine)
• A spike in urine output followed by marked drops in urine specific gravity 

This isn’t speculation. It’s chemistry.

⸻

Why This Matters for EMS, Cushing’s, or “Easy Keepers”

If your horse has:
• Equine Metabolic Syndrome (EMS)
• PPID (Cushing’s)
• A cresty neck or stubborn fat pads
• A history of laminitis
• Or just seems to “crash” after sedatives…

…they may already be genetically or hormonally predisposed to blood sugar mishandling. Guanabenz, in these cases, can tip the scale, sending their system into glucose overdrive before swinging hard the other way.

⸻

What You Might See:

Post-guanabenz red flags to watch for:
• Soaking wet bedding – frequent urination, especially within 1–3 hours after dosing
• Sticky or sweet-smelling urine – due to sugar spillover
• Excessive drinking – guarding buckets or draining troughs
• Unusual lethargy – a “glucose crash” after the sedation wears off
• Sweating or mild trembling – temperature regulation issues
• Signs of foot discomfort – shifting weight, short stride, warm hooves, bounding digital pulses

In short: the horse may look “off” for longer than expected—or even seem worse before better.

⸻

A Metabolic Storm Waiting to Happen?

While guanabenz has powerful benefits in the right context—especially for managing EIPH and calming anxious horses—it’s not a free pass for metabolically sensitive horses. Its sedative and analgesic effects can temporarily cover up early signs of sugar imbalance, making it easy to miss until the horse is already in distress.

⸻

Bottom Line

Guanabenz is more than a calming agent—it’s a metabolic modulator. For horses with blood sugar vulnerability, it could mimic, unmask, or worsen inherited glucose regulation disorders, much like what we see in humans with MODY or insulin resistance.

It’s not about fear—it’s about foresight.

If you’re using guanabenz (or any alpha-2 agonist) in a horse with known or suspected metabolic issues, be prepared:
• Monitor water intake and urination
• Check for signs of laminitis or sluggish recovery
• Support with metabolic-safe nutrition and hydration
• Work closely with your vet and always document what you see

Guanabenz may calm the nerves—but it can stir the sugar.

—

Sources:
• Lehner AF, Dirikolu L, Tobin T. Guanabenz in the horse – A preliminary report on clinical effects and comparison to clonidine and other alpha-2 adrenergic agonists. Pferdeheilkunde – Equine Medicine 38 (2022): 554–565. University of Kentucky Study

—

Disclaimer:
This post is for educational purposes only. The statements made here are not intended to diagnose, treat, cure, or prevent any disease. This product is not a substitute for veterinary care. Always consult with your veterinarian regarding your horse’s health and wellness needs.

05/11/2026

🔻 THE WORLD HEALTH ORGANIZATION JUST CLASSIFIED ELECTROMAGNETIC FREQUENCIES AS A "CLASS 1 THERAPEUTIC AGENT" IN AN INTERNAL DOCUMENT THAT WAS NEVER RELEASED TO THE PUBLIC. THE DOCUMENT IS DATED MARCH 14, 2026.

Not "alternative." Not "complementary." Not "under investigation." Class 1 Therapeutic Agent. The same classification as surgery and pharmaceutical intervention. Equal standing. Full recognition.

The document is 67 pages. Internal reference: WHO/HIS/SDS/2026.4. It was circulated to 14 member state health ministries on March 22nd. None of them published it. None of them held a press conference. None of them updated their national health guidelines.

A health ministry official in Estonia — a country with 1.3 million people and apparently less to lose — uploaded the document to a public health transparency portal on April 9th. It was removed within 4 hours. But the Wayback Machine archived it at 11:47 AM UTC.

⟁

The document states the following:

Electromagnetic frequencies between 0.1 Hz and 1000 Hz, when applied at specific amplitudes and durations, produce measurable therapeutic outcomes in:

— Bone regeneration (7.5 Hz pulsed field, 78% acceleration vs. control)
— Chronic pain reduction (10 Hz, 64% reduction in VAS scores)
— Wound healing (15 Hz, 41% faster epithelialization)
— Depression remission (10 Hz alpha entrainment, 52% remission rate vs. 23% SSRI)
— Insomnia resolution (3 Hz delta entrainment, 71% resolution within 21 days)
— Inflammation reduction (30 Hz, CRP decrease of 38% in 14 days)

Six conditions. Six frequency ranges. All outperforming pharmaceutical interventions in controlled trials cited within the document.

⟁

The WHO has known since at least 2019. The document references 340 peer-reviewed studies. 12 meta-analyses. 7 randomized controlled trials funded by WHO member states. The evidence was never in question. The classification was delayed for 7 years.

Why?

Page 51 contains a section titled "Economic Impact Assessment." It estimates that widespread adoption of frequency-based therapeutics would displace approximately $418 billion in annual pharmaceutical revenue across the six indicated conditions.

$418 billion. That is not a typo. That is the number they calculated. That is the number that kept this document internal for 7 years.

Depression alone: $28 billion in SSRI sales per year. A 10 Hz signal from a $200 device achieves higher remission rates. The math is not complicated. The silence is not accidental.

⟁

The classification is now official within WHO internal governance. It cannot be unwritten. It cannot be reclassified downward without a full General Assembly vote. The 14 member states that received it are now legally obligated under IHR Article 44 to "develop and implement" therapeutic frameworks based on new WHO classifications within 24 months.

24 months. March 2028. That is the deadline.

But Estonia already published it. The archive exists. The 67 pages are readable. The frequencies are listed. The protocols are described. The evidence is cited.

You don't need to wait for your government to tell you what the WHO already admitted internally. Frequencies heal. It's classified now. Not as conspiracy. As medicine.

340 studies. 67 pages. One classification that changes everything. They gave it to 14 governments and told none of them to tell you.

♟ They classified it as medicine and kept it classified. Share it before they reclassify the silence.